Insulin pumps for children

Vicky Alexander; Stephen Greene

doi:10.1016/j.paed.2009.03.016

Insulin pumps for children

Vicky Alexander, Stephen Greene

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

The use of intensive insulin strategies in children with type-1 diabetes mellitus (T1D) to improve glycaemic control has increased considerably in recent years, particularly in the US and Europe. In an attempt to give a more physiological insulin replacement, the use of continuous subcutaneous insulin infusion (CSII), delivered by insulin pump, is now well established in children. Technological advances mean that modern pumps are compact, 'user-friendly', and possess an excellent safety record. Recent guidance from the National Institute of Health and Clinical Excellence (NICE) indicates that CSII should be considered for many children with T1D. In this paper we review the pros and cons of this mode of treatment, and highlight the importance of CSII being delivered as part of a comprehensive package of care by a specialist paediatric diabetes team. We present some of our early experiences of insulin pump use and consider how CSII may develop in the future.

Original language	English
Pages (from-to)	316-320
Number of pages	5
Journal	Paediatrics and Child Health
Volume	19
Issue number	7
Early online date	29 May 2009
DOIs	https://doi.org/10.1016/j.paed.2009.03.016
Publication status	Published - 1 Jul 2009

Keywords

Child
Continuous subcutaneous insulin infusion
Diabetic ketoacidosis
Hypoglycaemia
Insulin pump
Type-1 diabetes mellitus

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.paed.2009.03.016

Cite this

@article{f6b2397d822d46fdbe1efa56454aef6f,

title = "Insulin pumps for children",

abstract = "The use of intensive insulin strategies in children with type-1 diabetes mellitus (T1D) to improve glycaemic control has increased considerably in recent years, particularly in the US and Europe. In an attempt to give a more physiological insulin replacement, the use of continuous subcutaneous insulin infusion (CSII), delivered by insulin pump, is now well established in children. Technological advances mean that modern pumps are compact, 'user-friendly', and possess an excellent safety record. Recent guidance from the National Institute of Health and Clinical Excellence (NICE) indicates that CSII should be considered for many children with T1D. In this paper we review the pros and cons of this mode of treatment, and highlight the importance of CSII being delivered as part of a comprehensive package of care by a specialist paediatric diabetes team. We present some of our early experiences of insulin pump use and consider how CSII may develop in the future.",

keywords = "Child, Continuous subcutaneous insulin infusion, Diabetic ketoacidosis, Hypoglycaemia, Insulin pump, Type-1 diabetes mellitus",

author = "Vicky Alexander and Stephen Greene",

year = "2009",

month = jul,

day = "1",

doi = "10.1016/j.paed.2009.03.016",

language = "English",

volume = "19",

pages = "316--320",

journal = "Paediatrics and Child Health",

issn = "1751-7222",

publisher = "Churchill Livingstone",

number = "7",

}

TY - JOUR

T1 - Insulin pumps for children

AU - Alexander, Vicky

AU - Greene, Stephen

PY - 2009/7/1

Y1 - 2009/7/1

N2 - The use of intensive insulin strategies in children with type-1 diabetes mellitus (T1D) to improve glycaemic control has increased considerably in recent years, particularly in the US and Europe. In an attempt to give a more physiological insulin replacement, the use of continuous subcutaneous insulin infusion (CSII), delivered by insulin pump, is now well established in children. Technological advances mean that modern pumps are compact, 'user-friendly', and possess an excellent safety record. Recent guidance from the National Institute of Health and Clinical Excellence (NICE) indicates that CSII should be considered for many children with T1D. In this paper we review the pros and cons of this mode of treatment, and highlight the importance of CSII being delivered as part of a comprehensive package of care by a specialist paediatric diabetes team. We present some of our early experiences of insulin pump use and consider how CSII may develop in the future.

AB - The use of intensive insulin strategies in children with type-1 diabetes mellitus (T1D) to improve glycaemic control has increased considerably in recent years, particularly in the US and Europe. In an attempt to give a more physiological insulin replacement, the use of continuous subcutaneous insulin infusion (CSII), delivered by insulin pump, is now well established in children. Technological advances mean that modern pumps are compact, 'user-friendly', and possess an excellent safety record. Recent guidance from the National Institute of Health and Clinical Excellence (NICE) indicates that CSII should be considered for many children with T1D. In this paper we review the pros and cons of this mode of treatment, and highlight the importance of CSII being delivered as part of a comprehensive package of care by a specialist paediatric diabetes team. We present some of our early experiences of insulin pump use and consider how CSII may develop in the future.

KW - Child

KW - Continuous subcutaneous insulin infusion

KW - Diabetic ketoacidosis

KW - Hypoglycaemia

KW - Insulin pump

KW - Type-1 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=65849314419&partnerID=8YFLogxK

U2 - 10.1016/j.paed.2009.03.016

DO - 10.1016/j.paed.2009.03.016

M3 - Article

AN - SCOPUS:65849314419

SN - 1751-7222

VL - 19

SP - 316

EP - 320

JO - Paediatrics and Child Health

JF - Paediatrics and Child Health

IS - 7

ER -

Insulin pumps for children

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this